Filter Results
:
(2,322)
Show Results For
-
All HBS Web
(8,229)
- Faculty Publications (2,322)
Show Results For
-
All HBS Web
(8,229)
- Faculty Publications (2,322)
health →
- Article
Transparency as a Solution for the Hospital Capacity Problem
COVID dramatically clarified a shortcoming in our great healthcare system, but like everything in the world, it has its shortcomings. What we see through the apex of COVID is that many hospitals in hotspot areas cannot provide an adequate supply of beds. Although the...
View Details
Herzlinger, Regina E. "Transparency as a Solution for the Hospital Capacity Problem." Ohio State Law Journal 82, no. 5 (December 2021): 787–794.
- November 2021
- Case
The Wolf in Cashmere: LVMH's Bid to Acquire Tiffany
By: Stuart C. Gilson and Sarah L. Abbott
In November 2019, the iconic U.S. jeweler Tiffany agreed to be acquired by the luxury goods conglomerate LVMH. The $16.6 billion transaction was scheduled to close in mid-2020. However, in 2020, the global COVID-19 pandemic took a toll on the luxury goods sector. In...
View Details
Keywords:
Mergers & Acquisitions;
Luxury Brand;
COVID-19 Pandemic;
Mergers and Acquisitions;
Health Pandemics;
Lawsuits and Litigation;
Consumer Products Industry;
United States;
Europe
Gilson, Stuart C., and Sarah L. Abbott. "The Wolf in Cashmere: LVMH's Bid to Acquire Tiffany." Harvard Business School Case 222-054, November 2021.
- November 2021 (Revised May 2022)
- Case
West Virginia: Finding the Right Path Forward
By: Matthew C. Weinzierl, Christine Keung and Reggie Smith
Once at the center of the American economy, the state of West Virginia had seen decades of decline as its coal industry fell on hard times. With beautiful but challenging topography, a proud but shrinking population, and a new scourge of the opioid epidemic, the...
View Details
Keywords:
Population Health;
Geographic Location;
Economic Slowdown and Stagnation;
Problems and Challenges;
Social Issues;
West Virginia
Weinzierl, Matthew C., Christine Keung, and Reggie Smith. "West Virginia: Finding the Right Path Forward." Harvard Business School Case 722-024, November 2021. (Revised May 2022.)
- November 2021
- Case
Kermit PPI
By: Kyle Myers, Matt Grennan and Sarah Mehta
Launched in 2011, Kermit PPI helped hospitals save money on expensive orthopedic implants and devices by enabling them to renegotiate their contracts with device manufacturers and better monitor compliance. In 2021, as they look to grow, they are entertaining two...
View Details
Keywords:
Health;
Health Care and Treatment;
Strategy;
Expansion;
Information Technology;
Applications and Software;
Supply Chain;
Supply Chain Management;
Contracts;
Health Industry;
Health Industry;
Health Industry;
United States;
Maryland
Myers, Kyle, Matt Grennan, and Sarah Mehta. "Kermit PPI." Harvard Business School Case 622-007, November 2021.
- November 2021
- Article
A Salient Sugar Tax Decreases Sugary Drink Buying
By: Grant E. Donnelly, Paige Guge, Ryan Howell and Leslie John
Many governments have introduced sugary drink excise taxes to reduce purchasing and consumption of such drinks; however, they do not typically stipulate how such taxes should be communicated at point-of-purchase. Historical, field, and experimental data entailing over...
View Details
Keywords:
Decision-making;
Open Data;
Open Materials;
Preregistered;
Health;
Policy;
Taxation;
Consumer Behavior;
Decision Making
Donnelly, Grant E., Paige Guge, Ryan Howell, and Leslie John. "A Salient Sugar Tax Decreases Sugary Drink Buying." Psychological Science 32, no. 11 (November 2021): 1830–1841.
- 2021
- Working Paper
COVID-19, Government Performance, and Democracy: Survey Experimental Evidence from 12 Countries
By: Michael Becher, Nicholas Longuet Marx, Vincent Pons, Sylvain Brouard, Martial Foucault, Vincenzo Galasso, Eric Kerrouche, Sandra León Alfonso and Daniel Stegmueller
Beyond its immediate impact on public health and the economy, the COVID-19 pandemic has put democracy under stress. While a common view is that people should blame the government rather than the political system for bad crisis management, an opposing view is that...
View Details
Keywords:
COVID-19 Pandemic;
Government Performance;
Democracy;
Health Pandemics;
Government and Politics;
Crisis Management;
Public Opinion
Becher, Michael, Nicholas Longuet Marx, Vincent Pons, Sylvain Brouard, Martial Foucault, Vincenzo Galasso, Eric Kerrouche, Sandra León Alfonso, and Daniel Stegmueller. "COVID-19, Government Performance, and Democracy: Survey Experimental Evidence from 12 Countries." NBER Working Paper Series, No. 29514, November 2021. (Revise and resubmit requested, The Journal of Politics.)
- November 2021
- Article
Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing
By: Tyler R. McClintock, David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan and George E. Haleblian
Objective. To characterize full cycle of care costs for managing an acute ureteral stone using time-driven activity-based costing.
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details
Methods. We defined all phases of care for patients presenting with an acute ureteral stone and built an... View Details
Keywords:
Time-Driven Activity-Based Costing;
Health Care and Treatment;
Cost;
Activity Based Costing and Management
McClintock, Tyler R., David F. Friedlander, Aiden Y. Feng, Mahek A. Shah, Daniel J. Pallin, Steven L. Chang, Angela M. Bader, Thomas W. Feeley, Robert S. Kaplan, and George E. Haleblian. "Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-driven Activity-based Costing." Urology 157 (November 2021): 107–113.
- 2021
- White Paper
Go Out and Innovate! Perspectives on Educating Health Care Leadership in the Time of Innovation
By: Regina E. Herzlinger, Anthony Stanowski, Edward Schumacher, Eugene Schneller, Kaveh Safavi, Quint Studer, Andrew Jay, Tom Robinson and Kevin Mahoney
The CAHME Innovation Council unanimously believes that education is essential. In evaluating the competency domain of management and leadership, and learning from programs that prioritize innovation, we ask how do we develop competencies in future leaders to succeed in...
View Details
Keywords:
Health Care;
Health Care Industry;
Health Care Entrepreneurship;
Innovation;
Innovation & Entrepreneurship;
Health Industry
Herzlinger, Regina E., Anthony Stanowski, Edward Schumacher, Eugene Schneller, Kaveh Safavi, Quint Studer, Andrew Jay, Tom Robinson, and Kevin Mahoney. "Go Out and Innovate! Perspectives on Educating Health Care Leadership in the Time of Innovation." White Paper, Commission on Accreditation of Healthcare Management Education (CAHME), November 2021.
- November 2021
- Article
Venture Capitalists and COVID-19
By: Paul A. Gompers, Will Gornall, Steven N. Kaplan and Ilya A. Strebulaev
We survey over 1,000 institutional and corporate venture capitalists (VCs) at more than 900 different firms to learn how their decisions and investments have been affected by the COVID-19 pandemic. We compare their survey answers to those provided by a large sample of...
View Details
Keywords:
Investment Decisions;
COVID-19 Pandemic;
Impact;
Health Pandemics;
Venture Capital;
Investment;
Decision Making;
Surveys
Gompers, Paul A., Will Gornall, Steven N. Kaplan, and Ilya A. Strebulaev. "Venture Capitalists and COVID-19." Journal of Financial and Quantitative Analysis 56, no. 7 (November 2021).
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone...
View Details
Keywords:
Clinical Supply Chain;
COVID-19;
Vaccine;
Agile;
Innovation and Invention;
Change Management;
Organizational Culture;
Transformation;
Leadership;
Corporate Strategy;
Health Pandemics;
Crisis Management;
Mission and Purpose;
Health Care and Treatment;
Supply Chain Management;
Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- Article
Potentially Long-Lasting Effects of the Pandemic on Scientists
By: Jian Gao, Yian Yin, Kyle R. Myers, Karim R. Lakhani and Dashun Wang
Two surveys of principal investigators conducted between April 2020 and January 2021 reveal that while the COVID-19 pandemic’s initial impacts on scientists’ research time seem alleviated, there has been a decline in the rate of initiating new projects. This dimension...
View Details
Gao, Jian, Yian Yin, Kyle R. Myers, Karim R. Lakhani, and Dashun Wang. "Potentially Long-Lasting Effects of the Pandemic on Scientists." Art. 6188. Nature Communications 12 (2021).
- October 26, 2021
- Article
Value Chain Management to Implement Post-COVID-19 Health Care Strategy: The COVID-19 Crisis Has Created Areas of Innovation That Should Be Embraced by Health Care Leaders
By: Michael E. Porter, Junaid Nabi and Thomas H. Lee
Health care organizations must learn from what has worked during the COVID-19 crisis. Leaders have found that while they cannot do everything, they must define and manage the sequence of activities required to deliver high-value care.
View Details
Keywords:
COVID-19 Pandemic;
Value-based Health Care;
Value Chain;
Health Pandemics;
Health Care and Treatment;
Management;
Strategy
Porter, Michael E., Junaid Nabi, and Thomas H. Lee. "Value Chain Management to Implement Post-COVID-19 Health Care Strategy: The COVID-19 Crisis Has Created Areas of Innovation That Should Be Embraced by Health Care Leaders." DOI: 10.1056/CAT.21.0302. NEJM Catalyst (October 26, 2021).
- October 2021 (Revised February 2022)
- Case
Hospital 57357: Aligning Performance Towards a Vision of a Cancer-Free Childhood
By: Susanna Gallani and Youssef Abdel Aal
The case follows the Children Cancer Hospital in Egypt, also known as Hospital 57357, as it goes through the roll-out of a new performance management system, which Dr. Sherif Abouel Naga, founder and CEO of the hospital, had championed. This was a critical juncture as...
View Details
Keywords:
Healthcare;
Performance Management;
Performance Incentives;
Strategic Alignment;
Health Care and Treatment;
Nonprofit Organizations;
Strategy;
Alignment;
Performance Evaluation;
Mission and Purpose;
Change Management;
Health Industry;
Egypt;
Middle East
Gallani, Susanna, and Youssef Abdel Aal. "Hospital 57357: Aligning Performance Towards a Vision of a Cancer-Free Childhood." Harvard Business School Case 122-041, October 2021. (Revised February 2022.)
- 2021
- Article
Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors
By: Jillian J. Jordan, Erez Yoeli and David Rand
COVID-19 prevention behaviors may be seen as self-interested or prosocial. Using American samples from MTurk and Prolific (total n = 6,850), we investigated which framing is more effective—and motivation is stronger—for fostering prevention behavior intentions. We...
View Details
Keywords:
COVID-19;
Prevention;
Prosocial Motivation;
Health Pandemics;
Behavior;
Motivation and Incentives
Jordan, Jillian J., Erez Yoeli, and David Rand. "Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors." Art. 20222. Scientific Reports 11 (2021).
- October 2021 (Revised October 2022)
- Case
The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide...
View Details
Keywords:
Opioids;
Drug;
Investors;
Shareholder Activism;
Investment Activism;
Executive Compensation;
Corporate Accountability;
Corporate Governance;
Governance Compliance;
Governance Controls;
Risk Management;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Business and Stakeholder Relations;
Legal Liability;
Health Industry;
Health Industry;
Health Industry;
United States;
West Virginia;
Tennessee;
Ohio;
Pennsylvania
Srinivasan, Suraj, and Li-Kuan Ni. "The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen." Harvard Business School Case 122-014, October 2021. (Revised October 2022.)
- October 2021
- Teaching Note
BRAC in 2020
By: Tarun Khanna and Shreya Ramachandran
Teaching Note for HBS Case No. 721-416.
View Details
- Article
Health Equity, Schooling Hesitancy, and the Social Determinants of Learning
By: Meira Levinson, Alan C. Geller, Joseph G. Allen and John D. Macomber
At least 62 million K-12 students in North America—disproportionately low-income children of color— have been physically out of school for over a year due to the COVID-19 pandemic. These children are at risk of significant academic, social, mental, and physical harm...
View Details
Keywords:
COVID-19;
Public Health;
Air Quality;
Social Determinants Of Health;
Schooling Hesitancy;
Vaccine Hesitancy;
Racial Injustice;
Inequity;
Inequality;
Health Pandemics;
Education;
Health Care and Treatment;
Policy;
Race;
Equality and Inequality
Levinson, Meira, Alan C. Geller, Joseph G. Allen, and John D. Macomber. "Health Equity, Schooling Hesitancy, and the Social Determinants of Learning." Art. 100032. Lancet Regional Health – Americas 2 (October 2021).
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was...
View Details
Keywords:
COVID-19 Pandemic;
Cost vs Benefits;
Trade;
Supply Chain;
Global Strategy;
Buildings and Facilities;
Operations;
Health Care and Treatment;
Demand and Consumers;
Global Range;
Globalized Markets and Industries;
Pharmaceutical Industry;
Italy;
China;
United States;
Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- 2021
- Working Paper
The Luck of the Draw: The Causal Effect of Physicians on Birth Outcomes
By: Arlen Guarin, Christian Posso, Estefania Saravia and Jorge Tamayo
Identifying the effect of physicians’ skills on health outcomes is a challenging task due to the nonrandom sorting between physicians and hospitals. We overcome this challenge by exploiting a Colombian government program that randomly assigned 2,126 physicians to 618...
View Details
Keywords:
Physicians' Health Skills;
Health Birth Outcomes;
Birthing Outcomes;
Experimental Evidence;
Health Care and Treatment;
Competency and Skills;
Outcome or Result;
Health Industry;
Colombia
Guarin, Arlen, Christian Posso, Estefania Saravia, and Jorge Tamayo. "The Luck of the Draw: The Causal Effect of Physicians on Birth Outcomes." Harvard Business School Working Paper, No. 22-015, February 2021. (R&R American Economic Journal.)
- September 13, 2021
- Article
Managing Through Crunch Time—Without Burning Out Your Team
By: Flavio Serapiao, Andrew Hill and Boris Groysberg
Crunch times—the long, stressful hours of work that are often required in the final weeks before a new product launch—can have an inordinate impact on the success of businesses and they’re powerful shapers of organizational culture. Effective leaders understand that...
View Details
Serapiao, Flavio, Andrew Hill, and Boris Groysberg. "Managing Through Crunch Time—Without Burning Out Your Team." Harvard Business Review Digital Articles (September 13, 2021).